803
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

“Am I carrier?” The patient's lived experience of thrombophilia genetic screening and its outcome

, &
Pages 696-712 | Received 29 Jul 2013, Accepted 23 Apr 2014, Published online: 04 Jun 2014

References

  • Almqvist, E. W., Brinkmann, R. R., Wiggins, S., & Hayden, M. R. (2003). Canadian collaborative study of predictive testing: Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease. Clinical Genetics, 64, 300–309.
  • Baglin, T. (2003). Management of thrombophilia: Who to screen? Pathophysiology of Haemostasis & Thrombosis, 33, 401–404.
  • Bank, I., Scavenius, M. P. R. B., Buller, H. R., & Middeldorp, S. (2004). Social aspect of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thrombosis Research, 113, 7–12.
  • Broadstock, M., Michie, S., & Marteau, T. (2000). Psychological consequences of predictive genetic testing: A systematic review. European Journal of Human Genetics, 8, 731–738.
  • Chapman, E., & Smith, J. A. (2002). Interpretative phenomenological analysis and the new genetics. Journal of Health Psychology, 7(2), 125–130.
  • Conroy, S. A. (2003). A pathway for interpretative phenomenology. International Journal of Qualitative Methods, 2(3), 36–62. Retrieved from http://ejournals.library.ualberta.ca/index.php/IJQM/article/view/4511
  • Constans, J., Boulon, C., Solanilla, A., & Conri, C. (2008). Therapeutic consequences of thrombophilic testing. La Revue de Medicine Interne, 29, 486–490.
  • Eatough, V., & Smith, J. A. (2008). Interpretative phenomenological analysis. In C. Willing & W. Stainton-Rogers (Eds.), Qualitative research in psychology (pp. 179–194). London: Sage.
  • Eichinger, S. (2009). Consequences of thrombophilia screening for life quality in woman before prescription of oral contraceptives and family members of VTE patients. Hämostaseologie, 29, 110–111.
  • Evers-Kiebooms, G., Welkenhuysen, M., Claes, E., Decruyenaere, M., & Denayer, L. (2000). The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers: Implications for multidisciplinary counseling and for genetic education. Social Science and Medicine, 51, 831–841.
  • Gartner, V., Weber, M., & Eichinger, S. (2008). The emotional impact of genetic testing and aspects of counselling prior to prescription of oral contraceptives. Contraception, 78, 392–398.
  • Goodman, D., Morrissey, S., Graham, D., & Bossingham, D. (2005). Illness representations of systemic lupus erythematosus. Qualitative Health Research, 15(5), 606–619.
  • Graffigna, G., & Olson, K. (2009). The “ineffable disease”: Exploring young people's discourse about HIV/AIDS in Alberta, Canada. Qualitative Health Research, 19(6), 780–801.
  • Hellmann, E. A., Leslie, N. D., & Moll, S. (2003). Knowledge and educational needs of the individuals with the factor V Leiden mutation. Journal of Thrombosis and Haemostasis, 1, 2335–2339.
  • Hertzberg, M. S. (2005). Genetic testing for thrombophilia mutations. Seminars in Thrombosis and Haemostasis, 31, 33–38.
  • Heshka, J. T., Palleschi, C., Howley, H., Wilson, B., & Wells, P. S. (2008). A systemic review of perceived risks, psychological and behavioural impacts of genetic testing. Genetics in Medicine, 10, 19–32.
  • Heshka, J., Palleschi, C., Wilson, B., Brehaut, J., Rutberg, J., Etchegary, H., … Wells, P. S. (2008). Cognitive and behavioural effects of genetic testing for thrombophilia. Journal of Genetic Counseling, 17(3), 288–296.
  • Hilgart, J., Mercer, J., & Thirlaway, K. (2013). Individuals’ experiences of, and responses to, a negative genetic test result for familial hypercholesterolaemia. Journal of Health Psychology, 18(3), 339–49.
  • Hill, E. M., & Gick, M. L. (2011). The big five and cervical screening barriers: Evidence for the influence of conscientiousness, extraversion and openness. Personality and Individual Differences, 50(5), 662–667.
  • Howard, A. F., Balneaves, L. G., Bottorff, J. L., & Rodney, P. (2011). Preserving the self: The process of decision making about hereditary breast cancer and ovarian cancer risk reduction. Qualitative Health Research, 21(4), 502–519.
  • Katalinic, D., & Plestina, S. (2010). Cancer epidemic in Europe and Croatia: Current and future perspectives. Journal of Public Health, 18(6), 575–582.
  • Leventhal, H., Nerenz, D. R., & Steele, D. J. (1984). Illness representations and coping with health threats. In A. Baum, S. E. Taylor, & J. E. Singer (Eds.), Handbook of psychology and health (Vol. 4, pp. 219–252). Hillsdale, NJ: Lawrence Erlbaum.
  • Levine, J. A. (1991). Are patients in favour of general health screening? Journal of the Royal Society of Medicine, 84, 280–283.
  • Lindqvist, P. G., & Dahlback, B. (2003). Reactions to awareness of activated protein C resistance carriership: A descriptive study of 270 women. Acta Obstetricia et Gynecolica, 82, 467–470.
  • Lodder, L., Frets, P. G., Trijsburg, R. W., Meijers Heijboer, E. J., Klijn, J. G., Duivenvoorden, H. J., & Niermeijer, M. F. (2001). Psychological impact of receiving a BRCA1/BRCA2 test result. American Journal of Medical Genetics, 98(1), 15–24.
  • Machin, S. J. (2003). Pros and cons of thrombophilia testing: Cons. Journal of Thrombosis and Haemostasis, 1, 412–413.
  • Mannucci, P. M. (2001). Genetic hypercoagulability: Prevention suggests testing family members. Blood, 98, 21–22. doi:10.1182/blood.V98.1.21
  • Marteau, T. M., & Croyle, R. T. (1998). The new genetics: Psychological responses to genetic testing. British Medical Journal, 316, 693–696.
  • Martinelli, I. (2003). Pros and cons of thrombophilia testing: Pros. Journal of Thrombosis and Haemostasis, 1, 410–411.
  • McCann, S., MacAuley, D., Barnett, Y., Bunting, B., Bradley, A., Jeffers, L., & Morrison, P. J. (2009). Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: A qualitative study. Psycho-Oncology, 18, 1208–1215.
  • Mendes, Á. F., Santos, T. A., & Sousa, L. (2011). Experiencing genetic counselling for hereditary cancers: The client's perspective. European Journal of Cancer Care, 20(2), 204–211.
  • Michie, S., Weinman, J., Miller, J., Collins, V., Halliday, J., & Marteau, T. M. (2002). Predictive genetic testing: High risk expectations in the face of low information. Journal of Behavioral Medicine, 25, 33–50.
  • Moore, T., Norman, P., Harris, P. R., & Makris, M. (2008). An interpretative phenomenological analysis of adaptation to recurrent venous thrombosis and heritable thrombophilia: The importance of multi-casual models and perceptions of primary and secondary control. Journal of Health Psychology, 13, 776–784.
  • Morse, J. M., Barrett, M., Mayan, M., Olson, K., & Spiers, J. (2002). Verification strategies for establishing reliability and validity in qualitative research. International Journal of Qualitative Methods, 1(2). Retrieved March 1, 2011, from http://ejournals.library.ualberta.ca/index.php/IJQM/article/view/4603
  • Nielsen, K. D., Dyhr, L., Lauritzen, T., & Malterud, K. (2004). “You can't prevent everything anyway”: A qualitative study of beliefs and attitudes about refusing health screening in general practice. Family Practice, 21, 28–32.
  • Nielsen, K. D., Dyhr, L., Lauritzen, T., & Malterud, K. (2009). “Couldn't you have done just as well without the screening?”: A qualitative study of benefits from screening as perceived by people without a high cardiovascular risk score. Scandinavian Journal of Primary Health Care, 27, 111–116.
  • Richards, L., & Morse, J. M. (2007). Readme first: For a user guide to qualitative methods (2nd ed.). Thousand Oaks, CA: Sage.
  • Riggs, A. L., & Giuliano, T. A. (2007). Running in the family or swimming in the gene pool: Discriminating between family history and genetic risk in illness perceptions. Journal of Health Psychology, 12(6), 883–894.
  • Saukko, P. M., Ellard, S., Richards, S. H., Shepherd, M. H., & Campbell, J. L. (2007). Patients’ understanding of genetic susceptibility testing in mainstream medicine: Qualitative study on thrombophilia. BMC Health Services Research, 7, 82–90.
  • Saukko, P. M., Richards, S. H., Shepherd, M. H., & Campbell, J. L. (2006). Are genetic tests exceptional? Lessons from a qualitative study on thrombophilia. Social Science & Medicine, 63, 1947–1959.
  • Senior, V., Smith, J. A., Michie, S., & Marteau, T. M. (2002). Making sense of risk: An interpretative phenomenological analysis of vulnerability to heart disease. Journal of Health Psychology, 7(2), 157–168.
  • Shaw, C., Abrams, K., & Marteau, T. M. (1999). Psychological impact of predicting individuals’ risks of illness: A systematic review. Social Science & Medicine, 49, 1571–1598.
  • Smith, J. A. (2011). Evaluating the contribution of interpretative phenomenological analysis. Health Psychology Review, 5(1), 9–27.
  • Smith, J. A., Flowers, P., & Larkin, M. (2009). Interpretative phenomenological analysis: Theory, method and research. London: Sage.
  • Smith, J. A., Jarman, M., & Osborne, M. (1999). Doing interpretative phenomenological analysis. In M. Murray & K. Chamberlain (Eds.), Qualitative health psychology (pp. 218–239). London: Sage.
  • Stewart, M., Brown, J. B., Weston, W. W., McWhinney, I. R., McWilliam, C. L., & Freeman, T. R. (Eds.). (1995). Patient centred medicine: Transforming the clinical method. London: Sage.
  • Stoate, H. G. (1989). Can health screening damage your health? Journal of the Royal College of General Practitioners, 39, 193–195.
  • Swanson, V., McIntosh, I. B., Power, K. G., & Dobson, H. (1996). The psychological effects of breast screening in terms of patients’ perceived health anxieties. British Journal of Clinical Practice, 50, 129–135.
  • Taylor, S. D. (2005). Predictive genetic test decisions for Huntington's disease: Elucidating the test/no-test dichotomy. Journal of Health Psychology, 10(4), 597–612.
  • Tluczek, A., Orland, K. M., & Cavanagh, L. (2011). Psychosocial consequences of false-positive newborn screens for cystic fibrosis. Qualitative Health Research, 21(2), 174–186.
  • Tripodi, A. (2005). A review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia. Seminars in Thrombosis and Hemostasis, 31(1), 25–32.
  • Van Korlaar, I. M., Vossen, C. Y., Rosendaal, F. R., Bovill, E. G., Naud, S., Cameron, L. D., & Kaptein, A. A. (2005). Attitudes toward genetic testing for thrombophilia in asymptomatic members of a large family with heritable protein C deficiency. Journal of Thrombosis and Haemostasis, 3, 2437–2444.
  • Vegni, E., Leone, D., Graffigna, G., Faioni, E., & Moja, E. A. (2013). To be or not to be: The patient's view of the thrombophilic screening test. Patient Education and Counselling, 90, 386–391.
  • Zolnierek, K. B. H., & DiMatteo, M. R. (2009). Physician communication and patient adherence to treatment. A meta-analysis. Medical Care, 47, 826–834.